Home/Filings/4/0001746473-25-000013
4//SEC Filing

Lefebvre Eric 4

Accession 0001746473-25-000013

CIK 0001746473other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 6:04 PM ET

Size

11.5 KB

Accession

0001746473-25-000013

Insider Transaction Report

Form 4
Period: 2025-01-23
Lefebvre Eric
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-23+91,30091,300 total
    Exercise: $11.14Exp: 2035-01-23Common Stock (91,300 underlying)
  • Award

    Common Stock

    2025-01-23+45,650240,224 total
Footnotes (2)
  • [F1]These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
  • [F2]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001614741

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 6:04 PM ET
Size
11.5 KB